This does look almost exactly like what you posted last time. But so what?
You are the person I believe that interpreted a DSMB report as somehow being a validation of the MEND trial design - or am I wrong about that?
Beyond doing a part way through the trial check to see that patients aren't actually worse off what does a data safety monitoring board's box checking actually amount to?
That is not a rhetorical question?
Yes its a milestone, but it would be staggeringly surprising to have failed to pass this milestone in my opinion.
Did anybody seriously consider that putting some stem cells into a high tech materials bandage was going to cause patients harm? When in the by now long history of doing a lot of different stuff with MSCs they never have?
Ann: Successful Completion of Planned DSMB Review of DFU Trial, page-22
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $43.39M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $34.48K | 147.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2250 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 19770 | 2 |
View Market Depth
| Last trade - 15.15pm 13/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |